Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) M Oshima, JE Dinchuk, SL Kargman, H Oshima, B Hancock, E Kwong, ... Cell 87 (5), 803-809, 1996 | 3091 | 1996 |
Characteristics and significance of the amorphous state in pharmaceutical systems BC Hancock, G Zografi Journal of pharmaceutical sciences 86 (1), 1-12, 1997 | 2355 | 1997 |
What is the true solubility advantage for amorphous pharmaceuticals? BC Hancock, M Parks Pharmaceutical research 17 (4), 397-404, 2000 | 1706 | 2000 |
Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures BC Hancock, SL Shamblin, G Zografi Pharmaceutical research 12 (6), 799-806, 1995 | 1181 | 1995 |
The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids BC Hancock, G Zografi Pharmaceutical research 11 (4), 471-477, 1994 | 916 | 1994 |
Crystallization of indomethacin from the amorphous state below and above its glass transition temperature M Yoshioka, BC Hancock, G Zografi Journal of pharmaceutical sciences 83 (12), 1700-1705, 1994 | 603 | 1994 |
Characterization of the time scales of molecular motion in pharmaceutically important glasses SL Shamblin, X Tang, L Chang, BC Hancock, MJ Pikal The Journal of Physical Chemistry B 103 (20), 4113-4121, 1999 | 396 | 1999 |
Modelling the mechanical behaviour of pharmaceutical powders during compaction CY Wu, OM Ruddy, AC Bentham, BC Hancock, SM Best, JA Elliott Powder technology 152 (1-3), 107-117, 2005 | 393 | 2005 |
The use of solubility parameters in pharmaceutical dosage form design BC Hancock, P York, RC Rowe International journal of pharmaceutics 148 (1), 1-21, 1997 | 390 | 1997 |
Differential scanning calorimetry: applications in drug development SD Clas, CR Dalton, BC Hancock Pharmaceutical science & technology today 2 (8), 311-320, 1999 | 378 | 1999 |
A modified Drucker-Prager Cap model for die compaction simulation of pharmaceutical powders LH Han, JA Elliott, AC Bentham, A Mills, GE Amidon, BC Hancock International Journal of Solids and Structures 45 (10), 3088-3106, 2008 | 374 | 2008 |
Inhibition of indomethacin crystallization in poly (vinylpyrrolidone) coprecipitates M Yoshioka, BC Hancock, G Zografi Journal of pharmaceutical sciences 84 (8), 983-986, 1995 | 329 | 1995 |
Process modeling in the pharmaceutical industry using the discrete element method WR Ketterhagen, MT am Ende, BC Hancock Journal of pharmaceutical sciences 98 (2), 442-470, 2009 | 295 | 2009 |
Predicting discharge dynamics from a rectangular hopper using the discrete element method (DEM) A Anand, JS Curtis, CR Wassgren, BC Hancock, WR Ketterhagen Chemical Engineering Science 63 (24), 5821-5830, 2008 | 267 | 2008 |
Predicting the flow mode from hoppers using the discrete element method WR Ketterhagen, JS Curtis, CR Wassgren, BC Hancock Powder technology 195 (1), 1-10, 2009 | 255 | 2009 |
Numerical and experimental investigation of capping mechanisms during pharmaceutical tablet compaction CY Wu, BC Hancock, A Mills, AC Bentham, SM Best, JA Elliott Powder Technology 181 (2), 121-129, 2008 | 218 | 2008 |
Granular segregation in discharging cylindrical hoppers: a discrete element and experimental study WR Ketterhagen, JS Curtis, CR Wassgren, A Kong, PJ Narayan, ... Chemical Engineering Science 62 (22), 6423-6439, 2007 | 204 | 2007 |
Modeling granular segregation in flow from quasi-three-dimensional, wedge-shaped hoppers WR Ketterhagen, JS Curtis, CR Wassgren, BC Hancock Powder Technology 179 (3), 126-143, 2008 | 193 | 2008 |
The relative densities of pharmaceutical powders, blends, dry granulations, and immediate-release tablets BC Hancock, JT Colvin, MP Mullarney, AV Zinchuk Pharmaceutical technology 27 (4), 64-64, 2003 | 179 | 2003 |
Interpretation of relaxation time constants for amorphous pharmaceutical systems SL Shamblin, BC Hancock, Y Dupuis, MJ Pikal Journal of pharmaceutical sciences 89 (3), 417-427, 2000 | 173 | 2000 |